Profile data is unavailable for this security.
About the company
OrbusNeich Medical Group Holdings Ltd is an investment holding company principally engaged in the development, production and sales of medical equipment and machineries. The Company is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The Company's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The Company mainly conducts its businesses in domestic and overseas markets.
- Revenue in HKD (TTM)1.20bn
- Net income in HKD352.17m
- Incorporated2021
- Employees1.25k
- LocationOrbusNeich Medical Group Holdings LtdNew Territories Hong KongHKG
- Phone+852 28022288
- Fax+852 25073532
- Websitehttps://orbusneich.com/
More ▼
Mergers & acquisitions
| Acquired company | 6929:HKG since announced | Transaction value |
|---|---|---|
| Eucatech AG | -41.77% | 2.61m |
Data delayed at least 15 minutes, as of Jun 07 2024 08:58 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gaush Meditech Ltd | 1.52bn | 187.28m | 2.36bn | 869.00 | 12.63 | 1.30 | 8.80 | 1.56 | 1.27 | 1.27 | 10.25 | 12.26 | 0.5057 | 2.34 | 8.85 | 1,746,534.00 | 6.22 | -- | 8.35 | -- | 49.18 | -- | 12.30 | -- | 1.19 | 5.90 | 0.2814 | -- | 12.16 | -- | 149.63 | -- | -- | -- |
| Venus MedTech HangZhou Inc | 530.33m | -759.55m | 2.48bn | 865.00 | -- | 0.7863 | -- | 4.67 | -1.73 | -1.73 | 1.21 | 7.15 | 0.1014 | 0.9402 | 1.65 | 613,102.50 | -15.04 | -13.20 | -17.41 | -14.97 | 79.21 | 79.51 | -148.37 | -152.83 | 1.86 | -8.78 | 0.2206 | -- | 20.89 | 33.62 | 33.46 | -- | 58.20 | -- |
| Zylox-Tonbridge Medical Technolgy Co Ltd | 569.60m | -84.98m | 3.84bn | 765.00 | -- | 1.14 | -- | 6.73 | -0.2586 | -0.2586 | 1.73 | 10.15 | 0.1592 | 0.9991 | 480.65 | 744,574.30 | -2.38 | -- | -2.56 | -- | 72.95 | -- | -14.92 | -- | 4.88 | -- | 0.018 | -- | 57.97 | -- | 30.66 | -- | -- | -- |
| OrbusNeich Medical Group Holdings Ltd | 1.20bn | 352.17m | 4.06bn | 1.25k | 11.59 | 1.41 | 10.54 | 3.37 | 0.4229 | 0.4229 | 1.44 | 3.48 | 0.4043 | 1.34 | 4.38 | 962,524.80 | 11.84 | -- | 12.86 | -- | 69.22 | -- | 29.29 | -- | 8.60 | -- | 0.0198 | -- | 12.45 | -- | 143.76 | -- | -- | -- |
| Modern Dental Group Ltd | 3.17bn | 404.10m | 4.45bn | 7.04k | 11.05 | 1.69 | 8.12 | 1.40 | 0.4245 | 0.4245 | 3.33 | 2.78 | 0.8468 | 9.10 | 5.49 | 450,895.30 | 10.74 | 7.05 | 12.60 | 8.34 | 53.61 | 50.77 | 12.68 | 9.24 | 2.53 | 13.17 | 0.2438 | 39.98 | 12.08 | 6.50 | 83.30 | 36.46 | 2.42 | -- |
| Shanghai Conant Optical Co Ltd | 1.90bn | 352.95m | 4.65bn | 2.51k | 13.17 | 3.09 | 11.20 | 2.45 | 0.8274 | 0.8274 | 4.45 | 3.53 | 0.9328 | 2.16 | 6.48 | 756,939.80 | 17.34 | 12.57 | 22.40 | 18.69 | 37.40 | 35.27 | 18.58 | 14.64 | 2.15 | -- | 0.1335 | 18.57 | 12.70 | 15.56 | 31.56 | 33.04 | 13.49 | -- |
| Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd | 351.74m | 163.55m | 4.81bn | 219.00 | 29.43 | 2.31 | 26.77 | 13.68 | 0.4717 | 0.4717 | 1.01 | 6.00 | 0.1717 | 0.5848 | 10.30 | 1,606,101.00 | 7.98 | -- | 8.25 | -- | 88.62 | -- | 46.50 | -- | 22.93 | -- | 0.0013 | -- | 31.58 | -- | 864.81 | -- | -- | -- |
| Shanghai INT Medical Instruments Co Ltd | 812.53m | 168.86m | 4.82bn | 1.57k | 27.83 | 2.62 | 22.25 | 5.94 | 0.9845 | 0.9845 | 4.73 | 10.46 | 0.3904 | 2.22 | 7.75 | 518,524.50 | 7.95 | 8.63 | 9.49 | 9.76 | 58.19 | 59.44 | 20.35 | 26.16 | 1.88 | -- | 0.0535 | 31.80 | 28.50 | 29.96 | 18.79 | 21.76 | 45.75 | -- |
| AK Medical Holdings Ltd | 1.18bn | 196.54m | 5.79bn | 1.05k | 29.39 | 2.24 | 19.64 | 4.90 | 0.1756 | 0.1756 | 1.05 | 2.30 | 0.3787 | 0.8406 | 2.38 | 1,122,237.00 | 6.30 | 9.27 | 7.52 | 11.28 | 61.66 | 65.06 | 16.65 | 21.78 | 2.77 | -- | 0.0431 | 22.65 | 3.97 | 12.74 | -11.07 | 4.67 | 21.67 | 5.88 |
Data as of Jun 07 2024. Currency figures normalised to OrbusNeich Medical Group Holdings Ltd's reporting currency: Hong Kong Dollar HKD
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 09 May 2024 | 82.50k | 0.01% |
| Parametric Portfolio Associates LLCas of 31 Mar 2024 | 18.50k | 0.00% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 8.75k | 0.00% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
| Ping An Fund Management Co., Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
